Company Announcement no. 80
Vejle, the 16.
INSIDER INFORMATION
Statement by Director
Following the IPO in mid-2019, we have been hit by production challenges in the transition from the development of a product to the initiation of automated production in
1. That our cornerstone investor,
2. Nasdaq stopped the listing of
3. That media, such as Jyllandsposten (by Jesper Høberg), Økonomisk Ugebrev (by
Initiates capital injection:
The potential of the three subsidiaries is intact.
It is the company's and external partners' expectations that within a few years the subsidiary Waturu will be able to sell units to a much greater extent than previously assumed and with greater profit as a result for Waturu and thus the shareholders.
The subsidiary
Watgen Medical A/S is in terms of development dependent on further validation of the product to create credibility. Based on successful validation, the market for wound care is global and there are approx. 2% of the population in the western world that suffers from chronic wounds, which is why the market potential is huge.
In addition to investments in the subsidiaries, the capital injection must at least ensure that the company has working capital for 12 months, which is inevitably the only requirement the company currently does not meet in order to have the shares admitted to trading on another stock exchange, which is the Board of Directors' ambition during 2022, so that there is again an active price and that the shares can be traded efficiently.
An external advisor will calculate an updated market value, which will form the basis for the offer price for the capital increase.
The tender is expected to be completed in October.
The company's shareholders will receive a detailed description of the offering by post.
In addition, the company is in dialogue with a Corporate Finance company, which is working on finding a loan of 15 MDKK, which will help the company with additional financing for growth.
The company also has a receivable of
Status of
The company consists of 3 subsidiaries,
The company must be provided with additional capital to start Danish production of the company's unique water heater. A water heater that is unique in being tankless, ultra-energy efficient, which kills bacteria in the water and which has a long life expectancy due to built-in anti-lime function.
The capital must, among other things, ensure that new molds can be produced, which should solve the production challenges and also that some technical specifications can be changed before the product must be subjected to new external tests (required for all changes), after which the sale can be initiated.
There is a dialogue about concluding a joint venture with a Danish / Pakistani company on production in
There is also dialogue with other actors who have similar interests.
Aquaturu A/S:
The company has entered into an agreement with a new director who will deposit 1 MDKK. The investment will not dilute existing shareholders in addition to
In addition, there is a dialogue with several investors, who together must ensure that the company can produce and sell the first reference units, after which
The market is global and the production of fish on land is growing rapidly, which requires new technical solutions that can ensure a more sustainable farming.
The company has received the first order from a large American company, which produces salmon on land and will find and enter into a reference with 5 Danish players.
Watgen Medical A/S:
The company is working on initiating further testing of a medico product, which will help to reduce infections and thus ensure faster wound healing in, for example, patients with chronic wounds. The validation will be carried out at a recognized foreign university. If the validation is positive, the company will be moved to the
The costs of the validation and reorganization of the company will require min. 1 MDKK in capital, after which it is expected that the company itself will be able to raise more capital in the
Forward communication:
Following the delisting from Nasdaq First North, the company will seek to pursue the current communications structure. Investors can sign up to receive a newsletter and in addition, investors can find information on the company's website under Investor Relations.
Trading in the company's shares must be registered with the company, which is required by law. Find more information on our website about how the registration is handled and what costs it entails as a consequence of the delisting.
After the delisting, the shareholders' shares will still appear in the shareholder's custody.
About
More information:
CEO
Sjællandsgade 32
7100 Vejle
Nasdaq First North Growth Market
Important links:
Website: www.greenimpactventures.com
Financial reports:
www.greenimpactventures.com/investor
Continuous updates from the company:
www.linkedin.com/company/greenimpactventures/
www.facebook.com/greenimpactventures/
© OMX, source